Implementing the Biopharmaceutics Classification System in Drug Development: Reconciling Similarities, Differences, and Shared Challenges in the EMA and US-FDA-Recommended Approaches
Crossref DOI link: https://doi.org/10.1208/s12248-016-9915-0
Published Online: 2016-04-26
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cardot, J.-M.
Garcia Arieta, A.
Paixao, P.
Tasevska, I.
Davit, B.
Text and Data Mining valid from 2016-04-26